Makris will be responsible for developing new business opportunities and driving organic growth with existing clients. The appointment of Makris builds on the firm’s global expansion plans and commitment to bringing leading-edge forecasting software and consultancy to even more industry-leading pharmaceutical corporations.
Speaking of his appointment, Makris said:
“I am delighted to announce my new role as J+D Forecasting’s Business Development Director. My decision to join J+D was influenced by my ambition to be part of an organisation which is leading the way in the pharma forecasting sector with real innovation, and can offer a specialist service to clients. With new software based offerings and some hugely exciting product launches in the pipeline, I’m joining the business at an extremely exciting time.”
David James, J+D Forecasting CEO, commented: “Mike’s experience and knowledge of the industry makes him perfectly placed to lead our next phase of growth. We’ve got some hugely exciting and innovative developments taking place over the next few months, and I am fully confident of Mike’s ability to drive our business forward as we continue to grow and cement our position in the market as pharma forecasting specialists.”
Makris joins J+D Forecasting from IQVIA, where he previously held the position of EMEA Solutions Sales Lead.
J+D Forecasting was founded over 10 years ago from a passion to support pharmaceutical companies with their forecasting needs. Providing bespoke consultancy services, sophisticated software, and interactive pharma forecasting training, J+D has extensive expertise in Oncology, Cardiology, Diabetes, Respiratory and Auto-immune diseases and has so far applied its knowledge and experience to over 30 countries.